Nirvana Life Sciences Inc.
NIRV
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 400.00 | 2.00K | 1.40K | 2.30K | 6.90K |
| Total Receivables | 13.60K | 13.70K | 13.60K | 13.80K | 17.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 20.40K | 19.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.00K | 15.70K | 15.00K | 36.60K | 44.50K |
|
|
|||||
| Total Current Assets | 14.00K | 15.70K | 15.00K | 36.60K | 44.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 121.70K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 126.40K | -- | -- | -- | -- |
| Total Assets | 140.50K | 15.70K | 15.00K | 158.30K | 44.50K |
|
|
|||||
| Total Accounts Payable | 109.80K | 134.60K | 131.70K | 120.40K | 101.90K |
| Total Accrued Expenses | 742.00K | 714.50K | 685.30K | 625.80K | 534.20K |
| Short-term Debt | 49.60K | 24.30K | 20.60K | 17.70K | 15.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 5.00K | 5.00K | 5.00K | 5.20K | 5.00K |
| Total Other Current Liabilities | 5.00K | 5.00K | 5.00K | 5.20K | 5.00K |
| Total Current Liabilities | 906.30K | 878.30K | 842.60K | 768.90K | 656.70K |
|
|
|||||
| Total Current Liabilities | 906.30K | 878.30K | 842.60K | 768.90K | 656.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 49.60K | 24.30K | 20.60K | 17.70K | 15.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 125.00K | 1.50K | -- | -- | -- |
| Total Liabilities | 1.03M | 879.80K | 842.60K | 768.90K | 656.70K |
|
|
|||||
| Common Stock & APIC | 4.97M | 5.01M | 5.04M | 5.18M | 4.99M |
| Retained Earnings | -6.27M | -6.28M | -6.27M | -6.18M | -5.96M |
| Treasury Stock & Other | 411.60K | 405.10K | 407.10K | 397.50K | 362.60K |
| Total Common Equity | -886.90K | -860.50K | -823.90K | -607.20K | -609.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -886.90K | -860.50K | -823.90K | -607.20K | -609.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.90K | -3.70K | -3.60K | -3.50K | -3.10K |
| Total Equity | -890.80K | -864.20K | -827.60K | -610.70K | -612.10K |
|
|
|||||
